Stay updated on Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.

Latest updates to the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.4.3 to v3.5.0. Added related topics including MedlinePlus Genetics and Multiple Myeloma.SummaryDifference0.2%

- Check8 days agoChange DetectedAdded Revision: v3.4.3. Removed 'Multiple myeloma' and 'MedlinePlus Genetics' related topics and the 'Revision: v3.4.2' note.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the page. The funding/status banner about government operations was deleted.SummaryDifference0.4%

- Check43 days agoChange DetectedA new top notice about government funding lapse and NIH Clinical Center operation status was added, with guidance to visit opm.gov for updates. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' were added, and the revision version changed from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check51 days agoChange DetectedAdded glossary display, 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed core term 'Multiple Myeloma' and related topics such as 'MedlinePlus Genetics', and updated QC-related labels, with a revision history change from v3.3.4 to v3.4.0.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded 'Multiple myeloma' as a topic. A Related topics section now links to MedlinePlus Genetics.SummaryDifference0.2%

Stay in the know with updates to Daratumumab for MRD Reappearance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for MRD Reappearance in Myeloma Clinical Trial page.